Medicina nuclear e Imagen molecular
INFORMACIÓN DE CONTACTO
Grupo de Investigación
ARBIZU LOSTAO, JAVIER
Correo Electrónico
jarbizu@unav.es
Martínez-Francés, E, Morán, V, Méndez, R, Domingo, C, Romero, AM, Martí-Climent, JM
"Neutron detectors in proton therapy: Calibration, operational in situ verification, and comparison with Monte Carlo simulation".
Radiat. Phys. Chem.. 228: 112362. 2025. [doi:10.1016/j.radphyschem.2024.112362]
Rosales JJ, Betech Antar V, Mínguez F, Pareja F, Guillén F, Prieto E, Quincoces G, Caballero FD, Miñana B, Pérez-Gracia JL, Rodríguez-Fraile M
"Comparison of staging using [(68)Ga]Ga-PSMA-11 PET/CT and histopathological results in intermediate- and high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection.".
Rev Esp Med Nucl Imagen Mol (Engl Ed). 44(2): 500076 - 500076. 2025. [doi:10.1016/j.remnie.2024.500076]
Durán-Lobato, M, Tovar, S, Cuñarro, J, Ramos-Membrive, R, Peñuelas, I, Marigo, I, Benetti, F, Chenlo, M, Alvarez, C, Ildikó, V, Urbanics, R, Szebeni, J, Alonso, MJ
"Bioinspired orthogonal-shaped protein-biometal nanocrystals enable oral protein absorption.".
J Control Release. 377: 17 - 36. 2025. [doi:10.1016/j.jconrel.2024.11.016]
Hernandez-Osuna, R, Lacalle, A, Gonzalez-Huarriz, M, Marco-Sainz, J, Palacios, D, Nuin, S, Morales, S, Perez-Larraya, JG, Patiño-García, A, Phoenix, T, Hernandez-Lain, A, Lassaletta, A, Blasco, L, Quincoces, G, Collantes, M, Solano, P, Alonso, MM, Labiano, S
"DEVELOPMENT AND CHARACTERIZATION OF A SPINAL CORD DIFFUSE MIDLINE GLIOMA MODEL".
Neuro-Oncology. 26. 2024. [doi:10.1093/neuonc/noae165.1271]
Cordoba, KM, Jericó, D, Jiang, L, Collantes, M, Alegre, M, García-Ruiz, L, Manzanilla, O, Sampedro, A, Herranz, JM, Insausti, I, de la Cuesta, AM, Urigo, F, Alcaide, P, Morán, M, Martin, MA, Lanciego, JL, Lefebvre, T, Gouya, L, Quinconces, G, Unzu, C, Hervas-Stubbs, S, Falcón-Pérez, JM, Alegre, E, Aldaz, A, Fernández-Seara, MA, Peñuelas, I, Berraondo, P, Martini, PG, Avila, MA, Fontanellas, A
"Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates".
Gut. 74(2). 2024. [doi:10.1136/gutjnl-2024-332619]
Scott, PJ, Penuelas, I, Rey, A, Aime, S, Ambikalmajan, PMR, Antunes, IF, Cleeren, F, Liu, ZF, Ellis, B, Kahts, M, Ekoume, FP, Chaple, IF, Bernardes, E, Behe, M, Huang, YY, Mikolajczak, R, Furumoto, S, Elrefaei, A, Kopka, K
"Highlight selection of radiochemistry and radiopharmacy developments by editorial board".
EJNMMI Radiopharm. Chem.. 9(1): 67. 2024. [doi:10.1186/s41181-024-00296-6]
Romera, M, M nguez, F, Betech, V, Basanta, A, Rosales, J, Garc a-Belaustegui, L, Tamariz, L, Panizo, M, Huerga, S, Rodriguez-Otero, P, San-Miguel, J, Garc a-Velloso, M
"Prognostic utility of baseline 18F-FDG PET/CT in patients with relapsed and refractory multiple myeloma treated with bispecific monoclonal antibodies.".
Eur. J. Nucl. Med. Mol. Imaging. 51: 168 - 169. 2024.
Romera, M, M nguez, F, Betech, V, Basanta, A, Rosales, J, Garc a-Belaustegui, L, Tamariz, L, Panizo, M, Huerga, S, Rodriguez-Otero, P, San-Miguel, J, del Rio, FP, Garc a-Velloso, M
"18F-FDG PET/CT imaging biomarkers in patients with Recurrent/Refractary Multiple Myeloma at baseline and post CAR-T Therapy for predicting clinical outcomes.".
Eur. J. Nucl. Med. Mol. Imaging. 51: 166 - 166. 2024.
|